Today: 8 November 2025
Subscribe
Browse Category

Investment News 3 November 2025 - 5 November 2025

Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST

Upstart Holdings’ AI Lending Revolution: Surging Growth, Stock Turmoil, and What’s Next for UPST

Company Overview: AI-Powered Lending Platform Upstart Holdings is a financial technology company founded in 2012 that has pioneered AI-driven lending. Instead of lending directly like a bank, Upstart runs a cloud-based platform that underwrites personal loans using artificial intelligence models, then connects approved borrowers with banks and credit unions that originate the loans gurufocus.com. Upstart earns fees from banks for the referrals and loan performance, rather than charging borrowers directly (the loans are made by partner lenders). This model allows Upstart to function as a tech intermediary – essentially an AI credit decision engine and marketplace – rather than a
5 November 2025
 ·  ·  ·  ·  · 
China Import Expo 2025 Shatters Records: $40B Deals, US Firms Return After Xi–Trump Summit – Experts Sound Off

China Import Expo 2025 Shatters Records: $40B Deals, US Firms Return After Xi–Trump Summit – Experts Sound Off

Expo Highlights & Speeches The CIIE is China’s flagship trade fair to demonstrate “free trade credentials” and attract imports reuters.com scmp.com. Premier Li stressed high-level opening-up, promising to keep China’s economy “fairer and more transparent” reuters.com. Reuters notes Li said rising tariffs “are seriously undermining international economic and trade rules” reuters.com. He repeated China’s commitment to increase imports of “high quality products” and let global companies expand with confidence reuters.com. This year’s expo will coincide with dozens of Hongqiao Economic Forum conferences on global economic governance. Shanghai’s Liu Liang (social sciences researcher) calls the expo a chance to see “innovative technologies”
5 November 2025
 ·  ·  ·  · 
Palantir Stock Skyrockets on Massive UK AI-Defense Pact – Could PLTR Eclipse Oracle by 2030?

Palantir Stock Forecast Through 2025

Palantir’s Current Stock Price & Valuation (November 2025) Palantir’s stock price in early November 2025 hovers around $190–$200 per share, after a slight post-earnings pullback. This is a staggering increase from roughly $15 two years ago. At ~$200/share, Palantir’s market capitalization is approximately $450 billion companiesmarketcap.com – a level on par with mega-cap tech names. This rally has firmly entrenched Palantir among the world’s most valuable tech firms. Year-to-date, the stock has gained ~170%, and over the past 12 months it’s up nearly 4× (+400%), vastly outperforming broader markets reuters.com reuters.com. Palantir was in fact one of the top S&P
4 November 2025
 ·  ·  ·  ·  · 
$100B in Crypto? How Digital Asset Treasury (DAT) Stocks Became the Hottest Trend in Finance

Bitcoin to $200K or More? Shocking End-of-2025 BTC Price Forecast Revealed

Current BTC Price and Market Status (November 2025) Bitcoin’s price in early November 2025 is hovering around the $105,000 mark, after a monumental rally and a healthy correction. Just weeks ago, BTC shattered its previous record, surging to a new all-time high above $126,000 in the first week of October markets.financialcontent.com. That rally – driven by unprecedented spot ETF inflows and bullish momentum – marked Bitcoin’s first foray well into six digits, far surpassing the ~$69K peak from 2021. However, late October brought a sharp pullback often dubbed the crypto market’s “Black Friday” of 2025, causing Bitcoin to dip below
4 November 2025
 ·  ·  ·  ·  · 
Wingstop Stock Soars as Growth Sizzles: Latest Price, News & Outlook

Wingstop Stock Soars as Growth Sizzles: Latest Price, News & Outlook

Customers enjoying Wingstop’s signature lemon-pepper wings with house-made ranch dip. The chain’s boldly flavored menu and digital-focused model have fueled a loyal fanbase and 21 consecutive years of same-store sales growth ir.wingstop.com. Current Stock Price & Recent Performance Wingstop’s stock price has experienced high volatility in recent days. After closing at $214 on Nov 3, 2025, shares surged to around $244 by mid-day Nov 4 following a strong earnings report stockanalysis.com. This ~14% single-day jump recouped losses from the prior week, when the stock had plunged abruptly – falling from the mid-$240s to the low $210s in late October. That
4 November 2025
 ·  ·  ·  ·  · 
Shopify’s 2025 Surge: Can the E-Commerce Powerhouse Keep Soaring?

Shopify Stock Skyrockets on Holiday Hopes Despite Profit Squeeze – What’s Next for SHOP?

Shopify’s logo. The e-commerce platform has seen explosive growth in sales (Q3 revenue up 32% YoY) but faces questions about rising costs and rich valuation. Its stock is up ~60% in 2025, and the company is forecasting a strong holiday quarter reuters.com reuters.com. Sources: Reuters reuters.com reuters.com reuters.com; Reuters (OpenAI partnership) reuters.com reuters.com; Reuters (Estée Lauder partnership) nasdaq.com nasdaq.com; 24/7 Wall St 247wallst.com 247wallst.com; Finviz finviz.com finviz.com; Nasdaq/Zacks nasdaq.com; Benzinga (JPMorgan quote) benzinga.com; BetaKit betakit.com betakit.com; Stockanalysis stockanalysis.com; Reuters (earnings report) reuters.com reuters.com.
4 November 2025
 ·  ·  ·  ·  · 
Marriott Stock Skyrockets on Luxury Travel Boom – Full 2025 Outlook & Analysis

Marriott Stock Skyrockets on Luxury Travel Boom – Full 2025 Outlook & Analysis

Now let’s dive deeper into each of these areas and what they mean for investors considering Marriott stock in late 2025. Latest News: Earnings Beat and Forecast Boost Marriott’s third-quarter 2025 earnings (released November 4) provided a dose of good news for shareholders. Earnings per share came in at $2.47, comfortably beating Wall Street’s ~$2.39 consensus reuters.com and marking a ~9% increase from the $2.26 adjusted EPS a year ago marketscreener.com. Revenue hit $6.49 billion, slightly above expectations of ~$6.46B reuters.com and up ~3.7% year-on-year. While top-line growth was modest, it’s notable given tough comparisons to 2024’s big post-pandemic rebound.
4 November 2025
 ·  ·  ·  ·  · 
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Indian Stock Market Plunges! Sensex Crashes 500 Points, ₹2 Lakh Crore Lost – Here’s Why

The Bombay Stock Exchange (BSE) building in Mumbai is depicted with a downward red arrow as Indian markets tumbled on November 4, 2025, erasing weeks of gains. livemint.com livemint.com Weak Global Cues Shake Dalal Street Global market turmoil was a major driver of today’s selloff in India. Stock exchanges across Asia and Europe saw deep cuts, setting a grim backdrop for Dalal Street. Profit-booking hit markets worldwide amid growing concern that U.S. stocks – especially the high-flying AI and big tech shares on Wall Street – have become overvalued and vulnerable to a sharp correction livemint.com. This fear of a
4 November 2025
 ·  ·  ·  · 
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Indices Reach Historic Peaks Tokyo’s key stock indices soared to record heights as October 2025 wrapped up, setting the stage for a strong start to November. On the final trading day before the Culture Day holiday, the Nikkei 225 leapt by 2.1% to close at 52,411.34 – its highest level ever reuters.com. This milestone also crowned an extraordinary October rally, with the Nikkei gaining 16.6% over the month (its best monthly performance in over 30 years) reuters.com. The TOPIX (broader Tokyo Stock Price Index) similarly notched an all-time closing high at 3,331.83 (up 0.9%) reuters.com, after touching an intraday peak
3 November 2025
 ·  ·  ·  · 
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

Market Overview: Indices End with Modest Gain Australian shares managed a slight rise on Monday, November 3, 2025, as the market shrugged off early weakness. The benchmark S&P/ASX 200 closed up 0.2% at 8,894.8 points indopremier.com, rebounding from morning lows. This marks a small advance following a tepid 0.4% gain for the entire month of October indopremier.com, indicating that the index remains near record-high territory. The broader All Ordinaries index of 500 companies was almost unchanged, dipping just 0.05% to 9,173.5 commbank.com.au. Overall, the market “finished roughly where it began” the day commbank.com.au, as strength in banking and tech shares
3 November 2025
 ·  ·  ·  · 
Solana (SOL) Price Rollercoaster: From $250 Uptober High to $185 – Will It Rebound to $300?

Solana’s Meteoric Rise: $175 Price, Game-Changing Upgrades & Wall Street’s Big Crypto Bet

SOL Price Trends and Market Performance (Nov 2025) After a tremendous rally earlier in 2025, Solana’s price is currently hovering around $175–$180 per token coinmarketcap.com. At this price, Solana’s market capitalization is in the ~$100 billion range coinmarketcap.com, firmly cementing it as a top-tier cryptocurrency (6th largest by market cap as of this week). Trading volumes remain healthy; for example, recent daily volume has been on the order of $3–8 billion USD coinmarketcap.com coinmarketcap.com, indicating significant liquidity and investor interest. Recent Price Action: SOL’s price has seen notable volatility in late October and early November 2025. Just last week, Solana
3 November 2025
 ·  ·  ·  · 
TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

TG Therapeutics Stock Soars on Briumvi Boom – Key Facts, Analyst Insights & 2025 Outlook

Company Overview: Briumvi-Focused Business Model TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in treatments for B-cell mediated diseases gurufocus.com. After years as a development-stage biotech, TG entered the commercial arena with Briumvi, its first approved product, and now generates the majority of revenue from Briumvi sales in the U.S. gurufocus.com. The company’s strategy centers on leveraging its expertise in B-cell biology to address both autoimmune disorders and B-cell cancers. Briumvi – A Breakthrough in Multiple Sclerosis Therapy Briumvi (ublituximab-xiiy) is TG’s flagship drug, approved by the FDA in December 2022 for adults with relapsing forms of multiple sclerosis
3 November 2025
 ·  ·  ·  ·  · 
1 2 3 4 … 25
Go toTop